These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 38590656)

  • 1. Mechanisms of angiogenesis in tumour.
    Zhang R; Yao Y; Gao H; Hu X
    Front Oncol; 2024; 14():1359069. PubMed ID: 38590656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy.
    Elebiyo TC; Rotimi D; Evbuomwan IO; Maimako RF; Iyobhebhe M; Ojo OA; Oluba OM; Adeyemi OS
    Cancer Treat Res Commun; 2022; 32():100620. PubMed ID: 35964475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour vascularization: sprouting angiogenesis and beyond.
    Hillen F; Griffioen AW
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):489-502. PubMed ID: 17717633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenesis in cancer therapeutics: the magic bullet.
    Oguntade AS; Al-Amodi F; Alrumayh A; Alobaida M; Bwalya M
    J Egypt Natl Canc Inst; 2021 Jul; 33(1):15. PubMed ID: 34212275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis.
    Cao Z; Shang B; Zhang G; Miele L; Sarkar FH; Wang Z; Zhou Q
    Biochim Biophys Acta; 2013 Dec; 1836(2):273-86. PubMed ID: 23933263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular co-option in resistance to anti-angiogenic therapy.
    Ribatti D; Annese T; Tamma R
    Front Oncol; 2023; 13():1323350. PubMed ID: 38148844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects.
    Huang M; Lin Y; Wang C; Deng L; Chen M; Assaraf YG; Chen ZS; Ye W; Zhang D
    Drug Resist Updat; 2022 Sep; 64():100849. PubMed ID: 35842983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited.
    Plate KH; Scholz A; Dumont DJ
    Acta Neuropathol; 2012 Dec; 124(6):763-75. PubMed ID: 23143192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular mimicry in cultured head and neck tumour cell lines.
    Upile T; Jerjes W; Radhi H; Al-Khawalde M; Kafas P; Nouraei S; Sudhoff H
    Head Neck Oncol; 2011 Dec; 3():55. PubMed ID: 22196216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation.
    Qian CN; Tan MH; Yang JP; Cao Y
    Chin J Cancer; 2016 Jan; 35():10. PubMed ID: 26747273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular co-option and vasculogenic mimicry mediate resistance to antiangiogenic strategies.
    Pezzella F; Ribatti D
    Cancer Rep (Hoboken); 2022 Dec; 5(12):e1318. PubMed ID: 33295149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance Mechanisms of Anti-angiogenic Therapy and Exosomes-Mediated Revascularization in Cancer.
    Zeng Y; Fu BM
    Front Cell Dev Biol; 2020; 8():610661. PubMed ID: 33363174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Vascular Endothelial Growth Factor-Dependent Sprouting Angiogenesis Assay Based on an In Vitro Human Blood Vessel Model for the Study of Anti-Angiogenic Drugs.
    Pauty J; Usuba R; Cheng IG; Hespel L; Takahashi H; Kato K; Kobayashi M; Nakajima H; Lee E; Yger F; Soncin F; Matsunaga YT
    EBioMedicine; 2018 Jan; 27():225-236. PubMed ID: 29289530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges.
    Siveen KS; Prabhu K; Krishnankutty R; Kuttikrishnan S; Tsakou M; Alali FQ; Dermime S; Mohammad RM; Uddin S
    Curr Vasc Pharmacol; 2017; 15(4):339-351. PubMed ID: 28056756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular regulators of cancer angiogenesis.
    Goh PP; Sze DM; Roufogalis BD
    Curr Cancer Drug Targets; 2007 Dec; 7(8):743-58. PubMed ID: 18220534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview on the Different Patterns of Tumor Vascularization.
    Ribatti D; Pezzella F
    Cells; 2021 Mar; 10(3):. PubMed ID: 33805699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signalling pathways in vasculogenic mimicry.
    Paulis YW; Soetekouw PM; Verheul HM; Tjan-Heijnen VC; Griffioen AW
    Biochim Biophys Acta; 2010 Aug; 1806(1):18-28. PubMed ID: 20079807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanisms of Resistance to Anti-Angiogenic Drugs.
    Filippelli A; Ciccone V; Donnini S; Ziche M; Morbidelli L
    Crit Rev Oncog; 2021; 26(2):39-66. PubMed ID: 34347972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.